ASSESSING THE IMPACT OF A MEDICAID PRIOR AUTHORIZATION (PA) POLICY FOR DULOXETINE ON ANTIPSYCHOTIC USE AMONG PATIENTS WITH DEPRESSION

被引：0
|
作者：
Birnbaum, H. G. [1 ]
Ivanova, J. I. [2 ]
Waldman, T. [1 ]
Swallow, E. [1 ]
Cummings, A. K. [1 ]
Clark, T. [3 ]
Peng, X. [3 ]
Swindle, R. [3 ]
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] Anal Grp Inc, New York, NY USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1619
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A68 / A69
页数：2
相关论文
共 50 条
  • [1] Medicaid Prior Authorization Policies for Pediatric Use of Antipsychotic Medications
    Schmid, Ian
    Burcu, Mehmet
    Zito, Julie M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (09): : 966 - 968
  • [2] The Effect of Medicaid Peer Review Prior Authorization Policies on Pediatric Use of Antipsychotic Medications
    Burcu, Mehmet
    Zito, Julie M.
    McKean, Stephen
    Warnock, Rob
    Herbert, Peter
    Verma, Sumit
    Worrall, Chris M.
    Chu, Steve
    Mohamadi, Ali
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 16 - 17
  • [3] Medicaid Prior Authorization Policies and Imprisonment Among Patients With Schizophrenia
    Goldman, Dana
    Fastenau, John
    Dirani, Riad
    Helland, Eric
    Joyce, Geoff
    Conrad, Ryan
    Lakdawalla, Darius
    AMERICAN JOURNAL OF MANAGED CARE, 2014, 20 (07): : 577 - 586
  • [4] Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications
    Farley, Joel F.
    Cline, Richard R.
    Schommer, Jon C.
    Hadsall, Ronald S.
    Nyman, John A.
    CLINICAL THERAPEUTICS, 2008, 30 (08) : 1524 - 1539
  • [5] EFFECT OF ATYPICAL ANTIPSYCHOTIC PRIOR AUTHORIZATION IMPLEMENTATION ON PATIENT OUTCOMES AMONG OHIO MEDICAID BENEFICIARIES
    Thompson, J. A.
    Kelton, C. M.
    Lin, A. C.
    Winstanley, E. L.
    Heaton, P. C.
    VALUE IN HEALTH, 2017, 20 (05) : A303 - A304
  • [6] Impact of NSAIDs prior authorization policy on patients' QoL
    Momani, AA
    Madhavan, SS
    Nau, DP
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (11) : 1686 - 1691
  • [7] Discontinuities in atypical antipsychotic therapy following prior authorization and step therapy among medicaid beneficiaries with schizophrenia
    Soumerai, S. B.
    Zhang, F.
    Ross-Degnan, D.
    Ball, D. E.
    Lecates, R. F.
    Law, M. R.
    Hughes, T. E.
    Chapman, D.
    Adams, A. S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 : 64 - 65
  • [8] Impact of prior authorization on use of angiotensin receptor blockers in US medicaid programs
    Fischer, Michael A.
    Choudhry, Niteesh K.
    Winkelmayer, Wolfgang C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S45 - S45
  • [9] Impact of medicaid prior authorization policies on use of angiotensin receptor blockers.
    Fischer, M. A.
    Choudhry, N. K.
    Winkelmayer, W. C.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 : 70 - 70
  • [10] Economic and clinical impacts of prior authorization for antipsychotic and anticonvulsant medications among medicaid beneficiaries with bipolar disorder
    Zhang, Y.
    Adams, A. S.
    Ross-Degnan, D.
    Zhang, F.
    Soumerai, S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 293 - 294
12345